Evidence map›Paper›PMID 42199635›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

Single-nucleus RNA sequencing identifies conserved structural cell programs in allergic lung inflammation.

Annamalai Govindhan, Aakash Sur, Koa Hosoki, Sanjiv Sur

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Annamalai GovindhanDepartment of Medicine, Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, Tex.
Aakash SurBiomedical and Health Informatics, School of Medicine, University of Washington, Seattle, Wash.
Koa HosokiDepartment of Medicine, Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, Tex.
Sanjiv SurDepartment of Medicine, Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, Tex.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung structural cells contribute to allergic airway inflammation; however, the lung cell type that mounts the most vigorous early transcriptional response to allergen exposure remains unclear. In this study, we used single-nucleus RNA sequencing to define early allergen-induced transcriptional programs across major lung structural cell populations. Objective: We sought to identify the lung structural cell type that exhibits a unique and robust transcriptional response following allergen challenge. Methods: Wild-type C57BL/6J mice were sensitized and challenged with cat dander extract. Lung tissues were collected 4 hours postchallenge to capture early transcriptional events and 72 hours to assess allergic inflammation. Single-nucleus RNA sequencing was performed on nuclei from frozen lung tissue. Transcript quantification, cell-type annotation, and differential gene expression analyses were conducted using Cell Ranger, CellTypist, iDEP, and gene set enrichment analysis. Results: Allergen challenge induced early transcriptional responses across lung structural cell populations. Capillary endothelial cells displayed the greatest number of unique allergen-induced genes and showed enrichment of transcriptional programs related to DNA damage, oxidative stress, and pathways associated with expansion of GATA-3 Conclusions: Capillary endothelial cells represent a dominant and early transcriptionally specialized responder to allergen exposure, characterized by coordinated activation of DNA damage/repair, oxidative stress, and T

Indexed as

allergic lung inflammationAT1/AT2 cellscapillary endothelial cellsclub cellsSingle-nucleus RNA sequencing

Identifiers

PMID42199635
PMCPMC13200110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.